Drug Profile
CB 0011
Alternative Names: CB0011Latest Information Update: 28 Sep 2015
Price :
$50
*
At a glance
- Originator Cypress Bioscience
- Class Sleep disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Sleep apnoea syndrome